The Value of Doppler Study of Central Retinal Artery in Diagnosis of Increased ICP
NCT ID: NCT05891678
Last Updated: 2023-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
66 participants
INTERVENTIONAL
2023-10-15
2025-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group (N)
Central retinal artery Doppler in patient with normal ICP
No interventions assigned to this group
Intervention group (H)
Central retinal artery Doppler in patient with increased ICP
doppler study of central retinal artery
pulsed wave Doppler after decreasing the sample volume to fit inside the center of CRA. We will measure the peak systolic velocity (PSV), end diastolic velocity (EDV), and the resistivity index which equal PSV-EDV/PSV, we will measure 3 times and the expected normal value is less than 0.7.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
doppler study of central retinal artery
pulsed wave Doppler after decreasing the sample volume to fit inside the center of CRA. We will measure the peak systolic velocity (PSV), end diastolic velocity (EDV), and the resistivity index which equal PSV-EDV/PSV, we will measure 3 times and the expected normal value is less than 0.7.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All Patients with traumatic brain injury including those on mechanical ventilation
Exclusion Criteria
* Patients with either arteritic or non arteritic central retinal artery occlusion
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inas Ahmed Sayed Ammar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Inas Ahmed Sayed Ammar
Head of intensive care unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo university Kas AL- Ainy Fuculty of medicine
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRA doppler in increased ICP
Identifier Type: -
Identifier Source: org_study_id